Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05444205Not ApplicableActive Not Recruiting

The Pittsburgh Study Early Childhood

Role: collaborator

NCT06516081Not ApplicableCompleted

Controlling Anemia During Pregnancy: Sprinkles Versus IFA Tablets

Role: collaborator

NCT00392418Not ApplicableCompleted

Flexible Administration of Sprinkles® in Infants and Young Children in Rural Bangladesh.

Role: collaborator

NCT00789490Phase 1Completed

Relative Bioavailability of Iron and Folic Acid in New Test Supplement

Role: collaborator

All 4 trials loaded